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ABSTRACT 
Fusarium keratoplasticum and Fusarium moniliforme are filamentous fungi common in 
the environment and cause mycosis in both animals and plants. Human infections 
include micetomas, keratitis and onychomycosis, while deeper mycosis occurs in 
immunocompromised patients. Most of the Fusarium spp. are frequently resistant to 
treatment with currently used antifungals. The frequent occurrence of antifungal 
resistance has motivated the study of antimicrobial photodynamic therapy as an 
alternative treatment for fungal infections. Many studies have investigated the in vitro 
use of antimicrobial photodynamic therapy to kill fungi, but rarely in animal models of 
infection. Thus, here we employed the invertebrate wax moth Galleria mellonella to 
study the in vivo effects of antimicrobial photodynamic therapy with three different 
phenothiazinium photosensitizers, methylene blue, new methylene blue N and the 
pentacyclic S137 against infection with microconidia of Fusarium keratoplasticum and 
Fusarium moniliforme. The effect of antimicrobial photodynamic therapy using these 
photosensitizers and light-emitting diodes with an emission peak at 635 nm and an 
integrated irradiance from 570 to 670 nm of 9.8 mW cm-2 was investigated regarding 
the toxicity, fungal burden, larval survival and cellular immune response. The results 
from this model indicate that antimicrobial photodynamic therapy with methylene blue, 
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new methylene blue N and  S137 is efficient for the treatment of infection with F. 
keratoplasticum and F. moniliforme. The efficiency can be attributed to the fungal cell 
damage caused by antimicrobial photodynamic therapy which facilitates the action of 
the host immune response.  
Keywords: antimicrobial photodynamic therapy; Fusarium keratoplasticum; Fusarium 
moniliforme; Galleria mellonella; mycosis.
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1. Introduction 
Photodynamic inactivation is a promising strategy to use in local infection control. It 
combines the interaction of a photosensitizer (PS), light and molecular oxygen. 
Photosensitizers are intentionally non-toxic molecules that are able to absorb and 
transfer energy or electrons after light absorption to molecular oxygen for the 
generation of reactive oxygen species (ROS), mainly singlet oxygen, which oxidize 
nonspecific microbial targets (Wainwright et al., 2017; Zhou et al., 2018). The 
advantages of antimicrobial photodynamic inactivation are double selectivity (light and 
PS localization), the very unlikely development of microbial resistance and efficient 
activity in multi-resistant strains (Hamblin and Hasan, 2004; Wainwright et al., 2017). 
The PSs initially proposed for antimicrobial use were phenothiazinium dyes (Bhatti et 
al., 1998; Wainwright et al., 1998; Gad et al., 2004), perylenequinones (Kubin et al., 
1999) and rose bengal (Schafer et al., 2000), , and. The first phenothiazinium dyes, 
thionin and methylene blue (MB), were described for the staining of specimens in 
biomedical microscopy. The versatile MB is a well-known cationic phenothiazinium dye 
and has been used and approved for clinical treatment (e.g. dementia, cancer and 
antimicrobial chemotherapy) (Dai et al., 2012; Wainwright et al., 2017). Despite the 
enormous existing confidence in commercial PS, the study of new molecules, including 
new derivatives of MB, offers great improvements in antimicrobial use (Wainwright, 
2009; Wainwright 2018; Wainwright et al., 2016; Wainwright and Crossley, 2002). New 
methylene blue (NMBN) is a close derivative of MB and was initially used for the 
routine staining of reticulocytes (Bain et al., 2017). NMBN is an active 
photoantimicrobial in vitro against Trichophyton sp. (Rodrigues et al., 2012), and 
Candida species (Rodrigues et al., 2013), and is a viable approach for prophylaxis and 
treatment of cutaneous infections caused by C. albicans (Dai et al., 2011). S137, also 
named DO15 (1,11-diethyl-2,2,4,8,10,10-hexamethyl-1,2,3,4,8,9,10,11-
octahydrodipyrido[3,2-b:2’,3’-i]phenothiazinium hydrogensulphate), is a pentacyclic 
phenothiazinium derivative of MB based on suitable tetrahydroquinolines (Wainwright 
et al., 2005; Wainwright et al., 2011). This MB derivative was studied in vitro for 
photoinactivation of bacteria and fungi. S137 is effective against the Gram-positive 
bacterium Propionibacterium acnes (Wainwright et al., 2012), and fungal species of the 
genera Trichophyton (Rodrigues et al., 2012), Candida (Rodrigues et al., 2013), 
Colletotrichum (de Menezes et al., 2014), Fusarium (de Menezes et al., 2016), and 
Neoscytalidium (Tonani et al., 2018). 
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Fusarium spp. are filamentous fungi easily dispersed in the environment via direct 
contact, water, wind and vectors. The fungal genus comprises several species that are 
well known plant and opportunistic human pathogens. Reports of human infections are 
growing due to both increasing numbers of immunocompromised patients and 
improved identification in the clinical laboratory (Al Hatmi et al., 2016). The most 
common clinically-important species is Fusarium solani species complex (e.g., F. 
falciforme, F. keratoplasticum and F. petroliphilum), followed by F. oxysporum, F. 
moniliforme (synonym F. verticillioides (Sacc.) Nirenberg), F. dimerum, and F. 
proliferatum (Al-Hatmi et al., 2016). Mycosis in humans, such as mycetoma (Katkar et 
al., 201, Bonifaz et al., 2018), keratitis (Homa et al., 2013) and onychomycosis 
(Guilhermetti et al., 2007) occurs in immunocompetent patients after traumatic 
introduction of Fusarium spp. Additionally, these species are associated with 
opportunistic infections in humans (e.g. neutropenic patients), causing localized 
infections in the skin and other body parts as well as systemic infections which are 
often difficult to treat and consequently associated with high mortality rates (Nucci and 
Anaissie, 2007). Difficulties in treatment are attributed to primary (intrinsic) and 
secondary resistance profiles of Fusarium spp. to currently used antifungals (Al Hatmi 
et al., 2016 and 2017). 
The antimicrobial properties of drugs have been studied by employing insect models of 
microbial infections such as the greater wax moth Galleria mellonella (Lionakis and 
Kontoyiannis, 2012). G. mellonella reproduces most of the aspects of mammalian 
infection and their larvae are increasingly used as an alternative model to study 
pathogenesis and virulence factors of several bacterial and fungal human pathogens. 
Among the advantages of employing in vivo testing with G. mellonella are the 
adaptation to mammalian temperature (37C); a well-characterized phagocytic system 
and immune repertoire; large numbers of larvae can be easily and inexpensively 
obtained in the lab, and no ethical considerations are required (Kelly and Kavanagh, 
2011; Giannouli et al., 2014). The immune system of G. mellonella has structural and 
functional similarities to the innate immune response of mammals. The insect 
hemolymph contains circulating hemocytes (immune cells) with the capacity to 
immobilize and/or kill microorganisms (Tsai et al., 2016). 
Here we investigate the in vivo effects of APDT with three different phenothiazinium 
PSs, MB, NMBN and S137 in the non-vertebrate model host Galleria mellonella larvae 
infected with microconidia of Fusarium keratoplasticum (F. solani species complex) and 
Fusarium moniliforme. 
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2. Methods 
2.1. Fungal strain, culture conditions and fungal inocula preparation 
The strains used in this study were Fusarium keratoplasticum Geiser et al. (Fusarium 
solani species complex) (ATCC®36031™) and Fusarium moniliforme Sheldon, 
anamorph (ATCC®38159™) both from the American Type Culture Collection (ATCC) 
(Manassas, VA, USA). Fusarium spp. were inoculated on Potato Dextrose Agar (PDA) 
media culture (Becton, Dickinson Company, USA) and incubated in the dark at 28ºC 
for 5 days. Microconidia were collected with sterile phosphate buffered saline (PBS), 
pH 7,4 and filtered with sterile Miracloth (Merck Millipore). Microconidia were counted 
using a hemocytometer and the suspension was diluted in sterile PBS. 
2.2. In vitro antifungal susceptibility test 
The tests were conducted according to the Clinical Laboratory Standards Institute 
(CLSI) reference method for broth dilution antifungal susceptibility testing of 
filamentous fungi (M38-A2) (Clinical and Laboratory Standards Institute, 2008). The 
antifungal drugs amphotericin B (AMB - 0.06 to 32 mg mL-1), fluconazole (FLU - 0.12 to 
64 mg mL-1), voriconazole (VOR - 0.03 to 16 mg mL-1), and posaconazole (POS - 0.12 
to 64 mg mL-1) were purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA). The 
experiments were performed in 96-well microtitre plates (TPP, Switzerland) with RPMI 
1614 culture medium (Gibco, Invitrogen Corporation, NY, USA) buffered with 0.165 M 
3-(N-morpholino) propanesulfonic acid (MOPS), pH 7.0, addition of antifungal drugs 
and 1 × 104 microconidia mL-1. After 48 h of incubation at 28ºC, the minimal inhibitory 
concentration (MIC) was visually determined. The MIC endpoint was defined as the 
minimal concentration of the drug capable of inhibiting 100% of fungal growth for AMB 
and inhibit 90% of fungal growth for azoles. The standard quality control strain of the 
experiment was Aspergillus flavus (ATCC®204304™). 
2.3. Photosensitizers and light source 
The phenothiazinium photosensitizers (PSs) methylene blue (MB) and new methylene 
blue N (NMBN) were purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA). The 
pentacyclic S137 was synthesized as previously described (Wainwright et al., 2011). 
The solutions and respective dilutions were prepared with sterile PBS. Stock solutions, 
chemical structures and light source (array of 96 light-emitting diodes with the emission 
peak at 635 nm and integrated irradiance from 570 to 670 nm of 9.8 mW cm-2) were 
previously described (de Menezes et al., 2016). The fluence of 15 J cm-2 was achieved 
after 19.5 minutes of light exposure. 
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2.4. Galleria mellonella as an non-vertebrate model for infection, toxicity and 
antimicrobial therapy tests 
Groups of 10 G. mellonella larvae were randomly divided to determine the infective 
inocula of F. keratoplasticum and F. moniliforme, toxicity of phenothiazinium PSs MB, 
NMBN, TBO and S137 and APDT efficacy in infections with microconidia of F. 
keratoplasticum and F. moniliforme. Additionally, fungal burden and cellular immune 
response were determined after APDT. G. mellonella larvae at the sixth instar of 
development were selected at 200 ± 50 mg each and an absence of cuticle 
pigmentation. A Hamilton syringe was used to inject 5 μL inoculum containing PBS 
(control), phenothiazinium PS and/or 104 microconidia of Fusarium spp. into the 
hemocoel of each larvae through the last right proleg. The larvae were exposed to dark 
(L-) or light (L+) in 24-well culture plate (Costar Corning, New York, NY, USA). After 
this, the larvae were maintained in glass containers in darkness at 37°C and monitored 
for survival daily. Survival curves and statistical analysis (Log-rank test, Mantel-Cox) 
were performed using GraphPad Prism 5 statistical software. P value <0.05 was 
considered statistically significant. 
The infective inocula of 101, 102, 103, 104 and 105 microconidia of F. keratoplasticum 
and F. moniliforme were tested in G. mellonella larvae with 5 µl injection of 2 × 103, 2 × 
104, 2 × 105, 2 × 106 and 2 × 107 microconidia suspension, respectively. The control 
group consisted of sterile PBS injected larvae. The experiments were repeated twice 
and representative experiments are presented. 
The toxicity of phenothiazinium PSs in G. mellonella were tested based on minimum 
fungicidal concentrations (MFC) determined by De Menezes et al. (2016). Given the 
PS distribution in the larvae, the concentrations were converted into molality (mol Kg-1) 
where the total mass consisted of the weight of the larvae (200 mg). The toxicity of MB 
was tested in G. mellonella at a final working concentration of 750, 1500 and 3000 µM. 
The final working concentration of NMBN and S137 were 100, 200 and 400 µM. Five 
microliters from the working concentration of each PS were injected in groups of G. 
mellonella larvae and the concentration of MB in each larva was, respectively, 18.75, 
37.5 and 75 µmol Kg-1. The concentration of NMBN and S137 were, respectively, 2.5, 5 
and 10 µmol Kg-1. The control group consisted of sterile PBS injected larvae. After PS 
injection, larvae were maintained in darkness or exposed to light (15 J cm-2). The 
experiments were repeated twice and representative experiments are presented. 
APDT with phenothiazinium PSs was evaluated in G. mellonella infected with F. 
keratoplasticum and F. moniliforme. The final concentration of microconidia injected in 
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each larva was 104 microconidia (5 µl of 2 × 106 microconidia mL-1). The final working 
concentration of phenothiazinium PSs were 750 and 1500 µM for MB, and 100 and 400 
µM for S137 and NMBN. The microconidial suspension was prepared in PBS or in the 
PS solution in which both microconidia and PS were injected together in 5 µl inoculum. 
The control group consisted of sterile PBS-injected larvae. Immediately after injection, 
the groups of larvae were maintained in darkness or exposed to light (15 J cm-2). The 
experiments were repeated twice and representative experiments are presented. 
The number of viable microconidia (fungal burden) and total hemocyte count (THC) 
were analyzed after APDT with MB (1500 µM), NMBN (200 µM) and S137 (200 µM) 
either maintained in darkness or exposed to light (15 J cm-2). After APDT the larvae 
were incubated 30 minutes in the dark and five larvae per group were bled using a 
sterile lancet into the hemocoel and the hemolymph was collected. 
The fungal burden was determined by the serial dilution of the hemolymph and 
inoculation on PDA supplemented with 0.12 mg mL-1 deoxycholic acid and 50 µg mL-1 
chloramphenicol. The numbers of colony-forming units (CFU) were counted after 48 h 
of incubation at 30ºC. The experiments were repeated twice and representative 
experiments are presented. 
The THC in the hemolymph of G. mellonella larvae were assayed using a protocol from 
Blanco et al. (2017). The experiment was performed with 3 larvae for each test 
condition. The hemolymph was collected and diluted in cold IPS (150 mM sodium 
chloride, 5 mM potassium chloride, 100 mM Tris hydrochloride ph 6.9, 10 mM EDTA 
and 30 mM sodium citrate). The hemocyte density was assessed with hemocytometer 
and observed under a light microscope (Coleman with 40× objective). The experiments 
were repeated twice and representative experiments are presented. 
3. Results 
3.1 Antifungal susceptibility test 
The antifungal susceptibility of F. keratoplasticum and F. moniliforme were tested to the 
polyene amphotericin B and three azoles, voriconazole, posaconazole and 
itraconazole. Aspergillus flavus was the control strain of the antifungal susceptibility 
experiment. The MIC values of the quality control strain were reproducible and fell 
within the established ranges published by CLSI methodologies (Clinical and 
Laboratory Standards Institute, 2008). The analysis revealed that itraconazole and 
posaconazole exhibited in vitro activity against F. keratoplasticum and F. moniliforme 
(MIC value 32 to > 64 µg mL-1). Voriconazole and amphotericin B were active with MIC 
ranges of 4 to 8 µg mL-1 and 1 to 2 µg mL-1, respectively (table 1). Therefore, the high 
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MIC values of itraconazole and posaconazole required to inactivate F. keratoplasticum 
and F. moniliforme indicate that these strains are resistant to these antifungal agents. 
3.2 Infective inoculum effect of F. keratoplasticum and F. moniliforme 
microconidia in G. mellonella larvae survival 
Microconidial inocula ranging from 101 to 105 microconidia/larva were used to 
investigate the virulence of F. keratoplasticum and F. moniliforme against G. mellonella 
(Figure 1). Inocula of 101, 102 and 103 microconidia/larva of F. keratoplasticum and 101 
microconidia/larva of F. moniliforme did not reduce larval survival until 9 days post-
infection compared to the uninfected control (PBS). However, inocula of 104 and 105 
microconidia/larva of F. keratoplasticum and 102 to 105 microconidia/larva of F. 
moniliforme reduced larval survival compared with lower inocula and uninfected 
controls (PBS). Therefore, larval survival was affected by the microconidial inoculum in 
a dose-dependent manner during 9 days incubation (Figure 1). The inoculum of 104 F. 
moniliforme microconidia/larva was able to kill 100% of the larvae at 4 days post-
infection. The same inoculum of F. keratoplasticum killed 100% of the larvae at 8 days 
post-infection (P ≤ 0.05 - Figure 1). The inoculum of 104 microconidia/larva was 
considered optimum for the production of acute infection with F. keratoplasticum and F. 
moniliforme in G. mellonella larva. 
 
3.3 Toxicity of APDT with phenothiazinium PSs to G. mellonella larvae 
The toxicity of phenothiazinium PSs MB, NMBN and S137 in darkness or with 
exposure to light (15 J cm-2) was tested in G. mellonella larvae. The exposure to light 
alone (without PS) at 15 J cm-2 did not affect larval survival. Similarly, treatment with 
NMBN (100, 200 and 400 µM) both in darkness and with light at 15 J cm-2 did not affect 
this. S137 (100, 200 and 400 µM) produced low mortality of the larvae (10 to 20%) in 
both darkness and with light. APDT with MB (750 and 1500 µM) killed only 10% of the 
larvae. However, the working concentration of 3000 µM of MB led to 50% mortality 
after 8 days (Figure 2). So, the phenothiazinium PSs MB, NMBN and S137 at the 
working concentration of 1500 µM, 200 µM and 200 µM, respectively, and exposure to 
15 J cm-2 were not toxic or presented low toxicity to G. mellonella and could be used in 
the treatment of Fusarium spp. infections. 
 
3.4 The effect of APDT with phenothiazinium PSs in G. mellonella infected with F. 
keratoplasticum and F. moniliforme 
The effect of APDT with MB, NMBN and S137 was evaluated in larvae of G. mellonella 
infected with 104 microconidia of F. keratoplasticum and F. moniliforme. Both species 
were able to kill 100% of the larvae, respectively, by the 5th and 7th days, respectively, 
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after microconidial injection (Figure 1). The injection of MB (1500 µM), NMBN (200 µM) 
and S137 (200 µM) in darkness did not prevent the death of most larvae infected with 
F. keratoplasticum and F. moniliforme (Figure 3 and 4). APDT was performed with two 
different concentrations of each PS and exposure  to 15 J cm-2. The survival of infected 
larvae with F. keratoplasticum were 60, 20 and 40% after APDT with MB (750 µM), 
NMBN (100 µM) and S137 (100 µM), respectively. F. moniliforme infected larvae 
demonstrated 20, zero and 90% survival after APDT with MB (750 µM), NMBN (100 
µM) and S137 (100 µM), respectively. At higher concentrations of PS, F. 
keratoplasticum infected larvae survival levels were 70, 60 and 80% after APDT with 
MB (1500 µM), NMBN (200 µM) and S137 (200 µM), respectively. The survival levels 
of larvae infected with F. moniliforme were 40, 10 and 100% after APDT with MB (1500 
µM), NMBN (200 µM) and S137 (200 µM), respectively. Therefore, the survival of 
infected larvae using APDT was improved by increasing the PS working concentrations 
to 1500 µM (MB), 200 µM (NMBN) and 200 µM (S137) (Figure 3 and 4). APDT with 
S137 was the most effective for both fungal species. 
 
3.5 Fungal burden in G. mellonella larvae after APDT with phenothiazinium PSs 
F. keratoplasticum and F. moniliforme burdens were determined in the hemolymph of 
infected larvae of G. mellonella after APDT with MB, NMBN and S137. Neither 
exposure only to light (15 J cm-2) nor treatment only with the PSs MB (1500 µM), 
NMBN (200 µM) and S137 (200 µM) killed the microconidia of F. keratoplasticum and 
F. moniliforme in infected larvae. Conversely, APDT with MB, NMBN and S137 in G. 
mellonella-infected larvae reduced the survival of F. keratoplasticum microconidia to 
38, 57 and 2%, respectively. The survival levels of F. moniliforme microconidia in 
infected-larvae were 69, 37 and 21%, respectively (Figure 5). This indicates that APDT 
with MB, NMBN and S137 in G. mellonella-infected larvae are able to significantly 
reduce the viability of F. keratoplasticum and F. moniliforme microconidia in vivo. 
 
3.6 Total hemocyte count of G. mellonella larvae after infection and APDT 
We investigated the total hemocyte count (THC) in the hemolymph of G. mellonella 
larvae in response to the infection with microconidia of F. keratoplasticum and F. 
moniliforme, and APDT with MB, NMBN and S137. The THC in naïve larvae (control 
group) was 137/L and increased to 253/L and 273/L in PBS-injected larvae in 
darkness and exposed to light (15 J cm-2), respectively. APDT (15 J cm-2) with the PS 
MB, NMBN and S137 in non-infected larvae has shown THCs greater than in non-
infected larvae with the same PS in dark conditions (Figure 6). Larvae infected with F. 
keratoplasticum and F. moniliforme had THCs of 159/L and 48/L, respectively. Once 
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the larvae was infected with microconidia of F. keratoplasticum and F. moniliforme, 
APDT (15 J cm-2) with MB, NMBN and S137 generally increased the THC, in 
comparison to the same treatment in dark conditions (Figure 06). The only exception 
was the decrease of THC in the APDT (15 J cm-2) with NMBN in larvae infected with F. 
keratoplasticum (figure 06). Regardless of the THC decreasing, the larval survival 
remained high after APDT (Figure 3). Thus, the results indicate that the inoculation of 
PBS in the larval hemolymph stimulates hemocyte proliferation. It is clearly shown that 
F. moniliforme poorly induces hemocyte proliferation in comparison to F. 
keratoplasticum, demonstrating that the cellullar immune stimulus depends on the 
species of the microorganism. Finally, the overall activity of APDT with MB, NMBN and 
S137 increases the THC in the hemolymph of both infected and non-infected larvae.  
Discussion 
In this study we evaluated APDT with two commercial (MB and NMBN) and one novel 
(S137) phenothiazinium PS in the in vivo model Galleria mellonella infected with 
microconidia of F. keratoplasticum and F. moniliforme. 
First we determined the virulence of F. keratoplasticum and F. moniliforme in G. 
mellonella. Different inocula of fungal microconidia were injected in the G. mellonella 
larvae. Based on the results, we observed that the virulence level of both species is 
dependent on the concentration of the microconidial inoculum. Additionally, we 
concluded that F. moniliforme is more virulent than F. keratoplasticum, showing that 
there are differences in virulence regarding strains and/or species. In a pathogenesis 
study, Fusarium species were able to kill Galleria mellonella larvae in a factor-
dependent manner, such as fungal strain, incubation temperature after larvae 
inoculation, and conidial morphology (Coleman et al., 2011). Clinical isolates of F. 
solani species complex have shown high virulence in a murine disseminated-infection 
model, while avirulence was presented by other species including F. verticillioides (= F. 
moniliforme) (Coleman et al., 2011). Therefore, the virulence of Fusarium species and 
strains to G. mellonella is surely dependent on diverse factors such as species, strains, 
temperature, host, conidial morphology and microconidial inoculum dose. 
Notwithstanding, we determined a lethal concentration of F. moniliforme and F. 
keratoplasticum microconidia against G. mellonella to study the effects of APDT in 
experimental infection assay. 
Fusarium spp. are considered multi-resistant pathogens (Baltazar et al., 2015) and are 
resistant to most antifungal agents (Nucci and Anaissie, 2007). Our results 
demonstrate the resistance of F. keratoplasticum and F. moniliforme to azoles. Indeed, 
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this resistance underlines the urgency of investigating new antifungal therapies. 
Antimicrobial photodynamic therapy (APDT) has proved to be an effective alternative 
approach to control fungal infections (Baltazar et al., 2015). The effect of APDT is the 
production of reactive oxygen species (ROS) which are highly reactive against fungal 
biomolecules (Hamblin and Hasan, 2004). Since many different fungal biomolecules 
are potentially damaged, the selection of resistant strains is greatly reduced, making 
APDT is promising therapeutic alternative against fungal infections. We tested the in 
vivo capacity of APDT with MB, NMBN and S137 by using larvae of the greater wax 
moth G. mellonella infected with microconidia of F. keratoplasticum and F. moniliforme. 
This model of infection has the potential to facilitate the in vivo study of pathogen-host 
cross talk (Chibebe Junior et al., 2013). We previously showed the in vitro efficacy of 
APDT with MB, NMBN and S137 against microconidia of F. keratoplasticum (F. solani 
species complex) and F. moniliforme (de Menezes et al., 2016). Our data indicated that 
treatment with MB (1500 M), NMBN (200 M) and S137 (200 M) was not toxic to G. 
mellonella larvae. We showed that  APDT with MB (1500 M), NMBN (200 M) 
prolonged and increased the survival of G. mellonella larvae infected with F. 
keratoplasticum and F. moniliforme. So far, this is the first study of APDT with MB, 
NMBN and S137 in G. mellonella larvae infected with microconidia of the filamentous 
fungi Fusarium spp. APDT with MB was studied in G. mellonella infected with the yeast 
fungus Candida albicans (Chibebe Junior et al., 2013) and the Gram-negative 
bacterium Porphyromonas gingivalis (Santos et al., 2017), and were able to prolong the 
survival of the infected larvae. MB and NMBN were effective in APDT of 
immunosuppressed mouse model of oral candidiasis infection (Freire et al., 2016). MB 
is often used since was the first antimicrobial PS clinically approved to human use (Dai 
et al., 2012). Skin ulcers infected with Fusarium spp. were successfully treated with MB 
and red light (Aspiroz et al., 2017). Therefore, APDT with MB and NMBN is effective in 
different hosts against different infecting microorganism, including azole-resistant 
strains of the filamentous fungi F. keratoplasticum and F. moniliforme.  
The production of new, potent and clinically compatible PSs is of increasing interest 
(Dai et al., 2012; Wainwright et al., 2017). We showed the in vitro effectiveness of the 
novel pentacyclic phenothiazinium PS S137 (de Menezes et al., 2016), and this is 
extended in the current work to demonstrate the in vivo effectiveness of APDT with 
S137 in G. mellonella larvae infected with microconidia of both F. keratoplasticum and 
F. moniliforme. S137 alone and APDT with S137 were not toxic to G. mellonella. The 
larvae presented a high survival rate after APDT with S137, indicating S137 as an 
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excellent PS for photodynamic therapy against filamentous fungi, such as the azole 
resistant strains of Fusarium spp. 
Organism survival after antifungal treatment depends on different factors inherent to 
the microorganism and host. The first includes the fungal cell damage caused by the 
treatment. The second includes the innate immune response (Bergin et al., 2003). The 
effect of APDT is the production of reactive oxygen species (ROS) which results in 
oxidative damage to the fungal biomolecules such as lipids, proteins and DNA. This 
damage usually reduces the viability of the cell (Hamblin and Hasan, 2004; Rosseti et 
al., 2014). Our group previously showed the in vitro damage caused by APDT with 
toluidine blue (TB), MB, NMBN and S137 to the cell permeability and lipids of F. 
keratoplasticum and F. moniliforme microconidia (de Menezes et al., 2016) and 
Neoscytalidium spp. arthroconidia (Tonani et al., 2018). Additionally, the in vitro killing 
effect was demonstrated (de Menezes et al., 2016), and is emphasized by the reduced 
microconidial viability reported here in vivo in G. mellonella larvae infected with F. 
keratoplasticum and F, moniliforme. Similar results were observed in G. mellonella 
infected with C. albicans, where APDT with MB decreased the yeast cell viability 
immediately after light exposure (Chibebe Junior et al., 2013). Additionally, the 
production of ROS and consequent cell permeability is increased in vitro in C. albicans 
upon APDT with TB (Rosseti et al., 2014). Thus, our results indicate that APDT with 
MB, NMBN and S137 reduced the microconidia viability due to fungal damage caused 
by the photochemical products of the treatment.  
An important factor to be considered for the survival of an organism is the immune 
system response to a microorganism invasion. In addition to monitoring the changes in 
the fungal load, changes in hemocyte density indicate fungal pathogenicity (Bergin et 
al., 2003). The cellular immune system response (circulating hemocyte) of G. 
mellonella larvae infected with microconidia of the mildly-virulent strain F. 
keratoplasticum was higher than the response of the larvae infected with the highly-
virulent F. moniliforme. The strains with high pathogenicity succeeded in dealing with 
the cellular immune response of the larvae which leads to the decrease in hemocyte 
count and increase in fungal development in the hemolymph. Thus, reduced hemocyte 
count is correlated to low larval survival and increase in hemocyte count is correlated to 
high larvae survival. 
We also evaluated the effect of APDT on the total hemocyte count in the hemolymph of 
non-infected and infected G. mellonella larvae. Overall, the total hemocyte count after 
APDT with MB, NMBN and S137 increased in larvae hemolymph whereas the fungal 
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burden was decreased. Similar results were found in APDT with MB against 
Porphyromonas gingivalis (Santos et al., 2017) and C. albicans (Chibebe Junior et al., 
2013). The increase in the cellular immune response here is correlated to the increase 
of larval survival and decrease of fungal burden. Thus, the infected larva survived 
because the cellular immune system response of G. mellonella acted effectively 
against fungal cells damaged by APDT with MB, NMBN and S137. 
 
Conclusion 
F. keratoplasticum and F. moniliforme are resistant to itraconazole (MIC 32 µg mL-1) 
and posaconazole (MIC > 64 µg mL-1). Antimicrobial photodynamic therapy with 
methylene blue (1500 µM), new methylene blue (200 µM),  and the pentacyclic 
derivative S137 (200 µM) are not toxic or present low toxicity to G. mellonella larvae 
and increase the survival of larvae infected with microconidia of both F. 
keratoplasticum and F. moniliforme. Increased larval survival was due to decreased 
inherent fungal burden and increased cellular immune response. 
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- TABLE - 
Table 01 – Susceptibility of F. keratoplasticum and F. moniliforme to commercial 
antifungal drugs. 
  VOR ITR POS AMB 
 
MIC (µg mL
-1
) 
F. keratoplasticum (ATCC®36031™) 8 64 > 64 1 
F. moniliforme (ATCC®38159™) 4 32 > 64 2 
Aspergillus flavus (ATCC®204304™) 0.5 0.25 0.25 1 
VOR, voriconazole; ITR, itraconazole; POS, posaconazole; AMB, amphotericin B; MIC, minimal 
inhibitory concentration. 
 
- FIGURES - 
Figure 1: Virulence of F. keratoplasticum and F. moniliforme in G. mellonella 
larvae. Larvae were infected with microconidia of F. keratoplasticum and F. 
moniliforme at the concentration of 1 × 101 to 1 × 105 microconidia/larva. Ten larvae 
were used in each condition and the survival was accompanied daily up to 9 days. 
PBS, phosphate buffer saline.  
Figure 2: Toxicity of phenothiazinium photosensitizers in G. mellonella larvae. 
Larvae were inoculated with MB, NMBN and S137. Ten larvae were used in each 
condition and the survival was accompanied daily up to 10 days. MB, methylene blue; 
NMBN, new methylene blue N; S137, pentacyclic MB derivative; PBS, phosphate 
buffer saline; light, 15 J cm-2; dark, light absence; PS, photosensitizer; 1×, 750 M (MB) 
and 100 M (NMBN and S137); 2×, 1500 M (MB) and 200 M (NMBN and S137); 3×, 
3000 M (MB) and 400 M (NMBN and S137). 
Figure 3: APDT in G. mellonella larvae infected with F. keratoplasticum. Larvae 
were infected with microconidia of F. keratoplasticum and submitted to APDT with MB, 
NMBN and S137. Ten larvae were used in each condition and the survival was 
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accompanied daily up to 10 days. MB, methylene blue; NMBN, new methylene blue N; 
S137, pentacyclic MB derivative; PBS, phosphate buffer saline; L-, dark; L+, 15 J cm-2; 
Fk, F. keratoplasticum; PS, photosensitizer; 1×, MB (750 M), NMBN and S137 (100 
M); 1×, 750 M (MB) and 100 M (NMBN and S137); 2×, 1500 M (MB) and 200 M 
(NMBN and S137). 
Figure 4: APDT in G. mellonella larvae infected with F. moniliforme. Larvae were 
infected with microconidia of F. moniliforme and submitted to APDT with MB, NMBN 
and S137. Ten larvae were used in each condition and the survival was accompanied 
daily up to 10 days. MB, methylene blue; NMBN, new methylene blue N; S137, 
pentacyclic MB derivative; PBS, phosphate buffer saline; L-, dark; L+, 15 J cm-2; Fm, F. 
moniliforme; PS, photosensitizer; 1×, 750 M (MB) and 100 M (NMBN and S137); 2×, 
1500 M (MB) and 200 M (NMBN and S137). 
Figure 5: Fungal burden in the hemolymph of G. mellonella after APDT with MB, 
NMBN and S137. Larvae were infected with microconidia of F. keratoplasticum and F. 
moniliforme and submitted to APDT with MB (1500 M), NMBN (200 M) and S137 
(200 M). After 30 min the hemolymph was collected.  CFU are presented as the mean 
and standard deviation of three larvae. *P  0.05; CFU, colony forming units; MB, 
methylene blue; NMBN, new methylene blue N; S137, pentacyclic MB derivative; L-, 
dark; L+, 15 J cm-2. 
Figure 6 : Total Hemocyte Count (THC)  in the hemolymph of G. mellonella larvae 
non infected and infected with F. keratoplasticum and F. moniliforme. Larvae 
were non infected and infected with microconidia of F. keratoplasticum and F. 
moniliforme, and submitted to APDT with MB (1500 M), NMBN (200 M) and S137 
(200 M). After 30 min the hemolymph was collected.  THC are presented as the mean 
and standard deviation of three larvae. Naïve, control larvae without inoculum; *P  
0.05; PBS, phosphate buffer saline; MB, methylene blue; NMBN, new methylene blue 
N; S137, pentacyclic MB derivative; L-, dark; L+, 15 J cm-2. 
 
